BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11729210)

  • 21. Amyloidosis of the renal pelvis: a harbinger of mammary carcinoma?
    Grigor T; Munro N
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25596296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organ-specific (localized) synthesis of Ig light chain amyloid.
    Hamidi Asl K; Liepnieks JJ; Nakamura M; Benson MD
    J Immunol; 1999 May; 162(9):5556-60. PubMed ID: 10228037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits.
    Casadonte R; Kriegsmann M; Deininger SO; Amann K; Paape R; Belau E; Suckau D; Fuchser J; Beckmann J; Becker M; Kriegsmann J
    Anal Bioanal Chem; 2015 Jul; 407(18):5323-31. PubMed ID: 25935672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Primary localized amyloidosis of the urinary bladder: a case report].
    Maeda N; Nishizaki S
    Hinyokika Kiyo; 1997 Jan; 43(1):53-5. PubMed ID: 9046424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biclonal systemic AL-amyloidosis with one glycosylated and one nonglycosylated AL-protein.
    Karimi M; Sletten K; Westermark P
    Scand J Immunol; 2003 Apr; 57(4):319-23. PubMed ID: 12662294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical study of immunoglobulin light chain amyloidosis with antibodies to the immunoglobulin light chain variable region.
    Hoshii Y; Kiyama M; Cui D; Kawano H; Ishihara T
    Pathol Int; 2006 Jun; 56(6):324-30. PubMed ID: 16704496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy.
    Silver MM; Hearn SA; Walton JC; Lines LA; Walley VM
    Am J Pathol; 1990 May; 136(5):997-1007. PubMed ID: 1693473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial amino acid sequence of an amyloid fibril protein from nodular primary cutaneous amyloidosis showing homology to lambda immunoglobulin light chain of variable subgroup III (a lambda III).
    Kitajima Y; Hirata H; Kagawa Y; Yaoita H
    J Invest Dermatol; 1990 Sep; 95(3):301-3. PubMed ID: 2117035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary localized amyloidosis of the bladder with a monoclonal plasma cell infiltrate.
    Bhagwandeen BS; Taylor S
    Pathology; 1988 Jan; 20(1):67-9. PubMed ID: 3131723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues.
    Foss GS; Nilsen R; Cornwell GC; Husby G; Sletten K
    Scand J Immunol; 1998 Apr; 47(4):348-54. PubMed ID: 9600316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational study.
    Mahmood S; Bridoux F; Venner CP; Sachchithanantham S; Gilbertson JA; Rowczenio D; Wagner T; Sayed R; Patel K; Fontana M; Whelan CJ; Lachmann HJ; Hawkins PN; Gillmore JD; Wechalekar AD
    Lancet Haematol; 2015 Jun; 2(6):e241-50. PubMed ID: 26688234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of somatic hypermutation and antigenic selection in the clonal B cell in immunoglobulin light chain amyloidosis (AL).
    Abraham RS; Geyer SM; Ramírez-Alvarado M; Price-Troska TL; Gertz MA; Fonseca R
    J Clin Immunol; 2004 Jul; 24(4):340-53. PubMed ID: 15163890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure and antigenic behaviour of kappa I-immunoglobulin light-chain amyloid proteins.
    Westermark P; Sletten K; Natvig JB
    Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):199-203. PubMed ID: 6171994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary amyloidosis of the bladder treated with partial cystectomy.
    Alsikafi NF; O'Connor RC; Yang XJ; Steinberg GD
    Can J Urol; 2003 Aug; 10(4):1950-1. PubMed ID: 14503942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Isolated primary amyloidosis of the bladder].
    Chamatan A; Peters C; Ngendahayo P; Maquet JH
    Prog Urol; 2004 Apr; 14(2):218-20. PubMed ID: 15217141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain.
    Kiyama M; Hoshii Y; Cui D; Kawano H; Kanda T; Ishihara T
    Pathol Int; 2007 Jun; 57(6):343-50. PubMed ID: 17539965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AH amyloidosis associated with an immunoglobulin heavy chain variable region (VH1) fragment: a case report.
    Miyazaki D; Yazaki M; Gono T; Kametani F; Tsuchiya A; Matsuda M; Takenaka Y; Hosh Y; Ikeda S
    Amyloid; 2008 Jun; 15(2):125-8. PubMed ID: 18484339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary amyloidosis of the urinary bladder.
    Huang CY; Shun CT; Huang KH; Chen J; Pu YS
    J Formos Med Assoc; 2006 Feb; 105(2):164-7. PubMed ID: 16477338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-lambda-light chain-peptide antibodies are suitable for the immunohistochemical classification of AL amyloid.
    Kuçi H; Ebert MP; Röcken C
    Histol Histopathol; 2007 Apr; 22(4):379-87. PubMed ID: 17290348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary structure of the variable region of a human lambda VI light chain: Bence Jones protein SUT.
    Frangione B; Moloshok T; Solomon A
    J Immunol; 1983 Nov; 131(5):2490-3. PubMed ID: 6415173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.